Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-05 4:38 pm Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Novo Holdings A/S | 12,893,250 3.1% | -9,746,417 (-43.05%) | View |
| 2020-10-05 4:47 pm Sale | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | Novo Holdings A/S | 22,639,667 5.4% | -408,832 (-1.77%) | View |
| 2020-08-03 4:18 pm Purchase | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | Growth Equity Opportunities Fund IV LLC | 42,638,131 10.2% | 31,111,112 (+269.90%) | View |
| 2020-07-31 4:05 pm Purchase | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | Abingworth LLP | 21,064,222 5.1% | 12,444,448 (+144.37%) | View |
| 2020-07-24 5:20 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Access Industries Holdings LLC | 44,444,448 10.7% | 44,444,448 (New Position) | View |
| 2020-07-24 4:30 pm Purchase | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | Novo Holdings A/S | 23,048,499 5.5% | 8,888,888 (+62.78%) | View |
| 2020-07-24 4:30 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Vivo Ventures VI LLC | 23,493,716 5.7% | 12,444,448 (+112.63%) | View |
| 2020-02-05 06:46 am Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Andera Partners | 2,348,814 2.2% | -4,303,584 (-64.69%) | View |